About Relmada
Relmada is a company based in Blue Bell (United States) founded in 2007.. Relmada has raised $12.96 million across 9 funding rounds from investors including BioAdvance and Ben Franklin Technology Partners. The company has 17 employees as of December 31, 2024. Relmada offers products and services including NDV-01. Relmada operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Blue Bell, United States
- Employees 17 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Relmada Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-79.98 M19.04as on Dec 31, 2024
-
EBITDA
$-83.89 M19.1as on Dec 31, 2024
-
Total Equity Funding
$12.96 M (USD)
in 9 rounds
-
Latest Funding Round
$825.75 K (USD), Post-IPO
Oct 08, 2019
-
Investors
BioAdvance
& 1 more
-
Employee Count
17
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Relmada
Relmada is a publicly listed company on the NASDAQ with ticker symbol RLMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Relmada
Relmada offers a comprehensive portfolio of products and services, including NDV-01. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating High-Grade Non-Muscle Invasive Bladder Cancer
Unlock access to complete
Unlock access to complete
Funding Insights of Relmada
Relmada has successfully raised a total of $12.96M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $825.75 thousand completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $825,750
-
First Round
First Round
(06 Jun 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Post-IPO - Relmada | Valuation |
investors |
|
| Jun, 2019 | Amount | Post-IPO - Relmada | Valuation |
investors |
|
| May, 2019 | Amount | Post-IPO - Relmada | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Relmada
Relmada has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BioAdvance and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Relmada
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Relmada
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Relmada Comparisons
Competitors of Relmada
Relmada operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Relmada
Frequently Asked Questions about Relmada
When was Relmada founded?
Relmada was founded in 2007 and raised its 1st funding round 6 years after it was founded.
Where is Relmada located?
Relmada is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.
Is Relmada a funded company?
Relmada is a funded company, having raised a total of $12.96M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $3.41M, raised on Jun 06, 2013.
How many employees does Relmada have?
As of Dec 31, 2024, the latest employee count at Relmada is 17.
What does Relmada do?
Relmada Therapeutics is a clinical-stage, publicly-traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities for the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse-resistant, sustained release dosage form of the opioid analgesic levorphanol.
Who are the top competitors of Relmada?
Relmada's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.
What products or services does Relmada offer?
Relmada offers NDV-01.
Is Relmada publicly traded?
Yes, Relmada is publicly traded on NASDAQ under the ticker symbol RLMD.
Who are Relmada's investors?
Relmada has 2 investors. Key investors include BioAdvance, and Ben Franklin Technology Partners.
What is Relmada's ticker symbol?
The ticker symbol of Relmada is RLMD on NASDAQ.